Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Acadia Pharmaceuticals has appointed Catherine Owen Adams to succeed Steve Davis as chief executive (CEO) and a member of its board of directors. 28 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD). 6 September 2024
Novocure (Nasdaq: NVCR) has announced that chief executive Asaf Danziger will retire at the end of 2024, with current chief financial officer Ashley Cordova set to succeed him as CEO. 4 September 2024
Lykos Therapeutics has announced a reorganization to best support the company as it works to address the resubmission of its new drug application (NDA) for midomafetamine capsules for the treatment of post-traumatic stress disorder (PTSD) in adults. 16 August 2024
German infectious disease specialist AiCuris Anti-infective Cures has announced the appointment of Cynthia Wat as chief medical officer (CMO). 30 July 2024
Ophirex, a registered public benefit corporation developing an oral field treatment to address the global unmet medical needs of snakebite victims, has announced the appointment of Jeremy Gowler as chief executive. 15 July 2024
US drugmaker AbbVie has announced that Roopal Thakkar, who currently serves as senior vice president, chief medical officer, global therapeutics, has been appointed to the position of executive vice president, research and development, and chief scientific officer (CSO). 10 July 2024
UK-based life sciences firm Abzena says that its US biomanufacturing subsidiary PacificGMP has made two senior appointments to support its growth. 23 February 2016
A new life sciences investment company, which includes former senior pharma industry executive, has commenced operations with initial funding from institutional investors. 22 February 2016
US pharma giant Pfizer has named the executive leadership team that will take up the reins after its acquisition of Irish-based Allergan is finalised at the end of this year. 9 February 2016
Astellas Pharma has announced the promotion of James Robinson as president, Americas operations, for Astellas US, with responsibility for the company's operations in North and South America, effective April 1, 2016. 8 February 2016
French drug major Sanofi on Friday named Muzammil Mansuri executive vice president, strategy & business development, effective February 22, 2016. 5 February 2016
Swiss pharma major Novartis, along with its financial results (see separate story) this morning, announced a major changes for its underperforming ophthalmic business Alcon, as well as some senior management appointments. 27 January 2016
Germany’s Merck on Wednesday announced two appointments to head its businesses in North America and China in a bid to strengthen its position in the regions. 27 January 2016
Valeant Pharmaceuticals’ chief executive Michael Pearson has said he is on the road to recovery but that he was uncertain about when he would return from medical leave. 26 January 2016
Germany's Merck KGaA said it has appointed Jessie English as the vice president of discovery, translational innovation platform immuno-oncology, effective February 16, 2016. 21 January 2016
Swedish Orphan Biovitrum today announced that Birgitte Volck, senior vice president of development and chief medical officer (CMO) of Sobi, will leave the company. 14 January 2016
Switzerland-based Cardiorentis AG said it has raised 60 million Swiss Franc ($60 million) via private investors to advance its Phase III trials for Ularitide, a therapy for acute decompensated heart failure (ADHF), including upcoming regulatory submissions expected in the second half of 2016. 11 January 2016
Shares in Valeant Pharmaceuticals dropped over 10% on December 28 after the company said chief executive Michael Pearson is taking a medical leave with immediate effect. 4 January 2016
US drugmaker MannKind Corp today announced the appointment of Duane DeSisto as its president and chief executive, effective January 5, 2016, replacing Alfred Mann who has served as interim CEO since November 19, 2015. 24 December 2015